In line with the above-mentioned requirements, an enormous amount of effort has been dedicated to the development of simple, specific, cheap, and portable testing chips for the rapid and efficient on-site detection of cTnI/cTnT biomarkers in order to diagnose and treat cardiovascular diseases at an incipient stage. Here, TNNT2 is linked to cardiovascular disorder.